STATISTICS

Some useful facts about MRC Technology

• Annual income from licensing activities (06/07) totalled GBP£56m (US$112m)
• 12 drugs based on MRC IP have marketing approval, including Humira® and Herceptin®
• MRCT has been involved in 17 start-up companies, including UCB Celltech and CAT
• There are currently 11 active programs in the Drug Discovery Group
• Monies awarded by the Development Gap Fund total GBP£4.4m (US$8m) to March 2007
• More than 20 companies are licensed to sell MRC research reagents